Loading clinical trials...
Loading clinical trials...
A Phase 1, Study of VX-828 in Healthy Subjects and in Subjects With Cystic Fibrosis
Conditions
Interventions
VX-828
Placebo
+7 more
Locations
12
United States
Joe DiMaggio Cycstic Fibrosis & Pulmonary Center
Hollywood, Florida, United States
AdventHealth Medical Group Pulmonology at Orlando Ridgewood
Orlando, Florida, United States
Altasciences Clinical Kansas
Overland Park, Kansas, United States
Kentucky Children's Hospital
Lexington, Kentucky, United States
Boston Children's Hospital
Boston, Massachusetts, United States
University of Minnesota -Pulmonology
Minneapolis, Minnesota, United States
Start Date
December 12, 2023
Primary Completion Date
April 23, 2026
Completion Date
April 23, 2026
Last Updated
April 14, 2026
NCT04469439
NCT02417740
NCT06984679
NCT05359991
NCT07484607
NCT06616857
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions